Annals of Oncology · 2014 · 178 citations · 19 references
MedicineOncologyPharmacologyMedical OncologyLung CancerLung Cancer PharmacotherapyMalignant NeoplasmsTelomere DysfunctionTelomere MaintenanceMaintenance Therapy TrialsNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii InvestigationTelomerase ActivationTelomerase EnzymeTelomerase FunctionTelomerase Inhibitors
19
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Telomeres shorten during ageing of human fibroblasts
Calvin B. Harley, A. B. Futcher, Carol W. Greider · Nature · 1990 · 5.7K citations
Education, Cell Biology, Genetics +11
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
J Oan H. S Chiller, D Avid H Arrington, C Handra P. B Elani et al. · 2002 · 3.7K citations
Medicine, Oncology, Pharmacology +11